Einhorn, Strander (1978) Interferon therapy for neoplastic diseases in man in vitro and in vivo studies. Human Interferon: Production and Clinical Use , W Stinebring, PJ Chaple, Plenum, New York; 159.
Ludwig, Swetly (1980) In vitro inhibitory effect of interferon on multiple myeloma stem cells. Cancer Immunol Immunother 9:139-143.
Gutterman, George, Blumenstein, Alexanian, Hweeyong, Buzdar, Cabanillas, Hortobagyi, Hersh, Rasmussen, Harmon, Kramer, Pestka (1980) Leukocyte interferon induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphomas. Ann Int Med 93:399-406.
Ahre, Bjoekholm, Mellstedt, Brenning, Engstedt, Gahrton, Gyllenhammar, Holm, Johannson, Jaernmark, Karnstroem, Killander, Lerner, Lockner, Loennqvist, Nilsson, Simonsson, Stalfelt, Strander, Svedmyr, Wadman, Wedelin (1984) Human leukocyte interferon and intermittent high dose melphalan/prednisone administration in the treatment of multiple myeloma. A randomized clinical trial , 10th edn., Cancer Treat Rep; 68:1331-1338.
Committee of the Chronic Leukemia Myeloma Task Force -NCl (1973) Proposed guidelines for protocol studies. Cancer Chemother Rep 4:145-158.
Kaplan, Meier (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53:457-481.
Costanzi, Cooper, Scarffe, Ozer, Grubbs, Ferraresi, Pollard, Spiegel (1985) Phase II study of recombinant alpha-2C interferon in resistant multiple myeloma. J Clin Oncol 3:654-659.
Ezaki, Ogawa, Okabe, Abe, Inove, Horikoshi, Inagaki (1982) Clinical and immunological studies of human fibroblast interferon. Cancer Chemother Pharmacol 8:47-55.
Misset, Mathe, Gastiaburn, Goutner, Dorval, Gouveia, Hayat, Jasmin, Schwarzenberg, Machover, Ribaud, De Vassal, Horoszewics (1982) Treatment of lymphoid neoplasia by interferon. I. Human fibroblastic interferon (beta) in malignant gammapathies phase II trial. Anticancer Res 2:63-66.
Billiau, Bloemmen, Bogaerts, Claeys, Van Damme, De Ley, De Somer, Drochmans, Heremans, Kriel, Schetz, Tricot, Vermylen, Waer (1981) Interferon therapy in multiple myeloma: Failure of human fibroblast interferon administration to alter the course of light chain disease. Eur J Cancer 17:875-882.
Alexanian, Gutterman, Levy (1982) Interferon treatment for multiple myeloma. Clinics in Haematology , SE Salmon, Saunders, London, Philadelphia, Toronto; 211-220.
Aapro, Alberts, Salmon (1983) Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay. Cancer Chemother Pharmacol 10:161-166.
Welander, Gaines, Homesley, Rudnick (1983) In vitro synergistic effects of recombinant human interferon alpha2 (rIFN-α2) and doxorubicin on human tumor cell lines. Proc ASCO , 10th edn.; 2:42.
Cooper, Fefer, Thompson, Bickers, Kempf, Sacher, Neefe, Case, Scarffe, Bonnem (1985) Alpha-2 interferon (IFN), melphalan (M), and prednisone (P) in the treatment of newly diagnosed multiple myeloma (MM). Proc ASCO , 10th edn.; 4:216.
Welander, Muss, Homesley, Spiegel (1985) Phase II trial of combined human interferon alpha-2 (rIFN-α2) and doxorubicin (DOX) in advanced solid tumors. Proc ASCO , 10th edn.; 4:220.
Clark, Dimitrov, Axelson, Charamella (1984) Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy. J Biol Response Modifiers 3:613-619.
